KR890002111A - 벤즈이미다졸 유도체, 그의 제법 및 치료에의 이용 - Google Patents

벤즈이미다졸 유도체, 그의 제법 및 치료에의 이용 Download PDF

Info

Publication number
KR890002111A
KR890002111A KR1019880009229A KR880009229A KR890002111A KR 890002111 A KR890002111 A KR 890002111A KR 1019880009229 A KR1019880009229 A KR 1019880009229A KR 880009229 A KR880009229 A KR 880009229A KR 890002111 A KR890002111 A KR 890002111A
Authority
KR
South Korea
Prior art keywords
compound
coch
hydrogen
reacted
methyl
Prior art date
Application number
KR1019880009229A
Other languages
English (en)
Inventor
마누리 필리쁘
로씨 귀이
비네 쟝
드포쓰 제라르
자브리 나지브
Original Assignee
에.뚜레 레메뜨르
신떼라보 소시에떼 아노님
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에.뚜레 레메뜨르, 신떼라보 소시에떼 아노님 filed Critical 에.뚜레 레메뜨르
Publication of KR890002111A publication Critical patent/KR890002111A/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Liquid Developers In Electrophotography (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

내용 없음

Description

벤즈이미다졸 유도체, 그의 제법 및 치료에의 이용
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (5)

  1. 식(1)에 해당하는 벤즈이미다졸 유도체 및 약학상 허용되는 산과의 그의 부가염 및 토오토머 형태의 화합물.
    상기식에서, R1은 수소원자 또는 메틸기를 나타내고, R2는 수소원자, 메틸기 또는 아세틸기를 나타내며, R3는 수소원자, 메틸기 또는 아세틸기를 나타내고, R4는 수소 또는 할로겐원자이다.
  2. 제1항에 따르는 화합물의 제조방법에 있어서,
    1. 화합물(II)
    을 시안아미드와 반응시키고 이것은 화합물(I) a
    (여기서 R1, R2및 R3의 각각은 수소원자임)를 가져오고, 원한다면, 이 화합물(I)a를 다음에 아세트산 무수물과 반응시켜 화합물(I)b
    (여기서 R1은 H이고 R2는 COCH3이며 R3는 H 또는 COCH3임)를 얻거나,
    2. 아니면 화합물(II)
    를 티오시안산칼륨 또는 메틸이소티오시아네이트와 먼저 반응시킨 다음 요오드화메틸과 반응시켜 화합물(III)
    (여기서, R3는 H 또는 CH3임)을 얻는데, 이것을 암모니아와 반응시키거나 메틸아민과 반응시키거나 디메틸아민과 반응시켜, R1이 H 또는 CH3이고 R2가 H 또는 CH3이고 R1H 또는 CH3인 화합물(I)a를 얻는 다음, 원한다면, 이들 화합물(I)a중 한가지를 아세트산 무수물과 반응시켜 R1이 CH3이고, R2가 COCH3이며 R3가 H, CH3또는 COCH3이거나, R1이 CH3, R2가 H 또는 CH3, R3가 COCH3이거나, R1이 H, R2와 R3중 하나가 CH3이고 R3와 R3중 다른 하나는 COCH3인 화합물(I)b를 얻는 것을 특징으로 하는 제조방법.
  3. 제1항에 명시된 것과 같은 화합물을 함유하는 것을 특징으로 하는 의약.
  4. 어떤 적합한 부형제와 조합하여 제1항에 명시된 것과 같은 화합물을 함유하는 것을 특징으로 하는 약학조성물.
  5. 제1항에 명시된 화합물의 합성중간체로서의 이용.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019880009229A 1987-07-23 1988-07-22 벤즈이미다졸 유도체, 그의 제법 및 치료에의 이용 KR890002111A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR87/10409 1987-07-23
FR8710409A FR2618435B1 (fr) 1987-07-23 1987-07-23 Derives de benzimidazole, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
KR890002111A true KR890002111A (ko) 1989-04-08

Family

ID=9353449

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880009229A KR890002111A (ko) 1987-07-23 1988-07-22 벤즈이미다졸 유도체, 그의 제법 및 치료에의 이용

Country Status (19)

Country Link
US (1) US4857536A (ko)
EP (1) EP0304353B1 (ko)
JP (1) JP2690749B2 (ko)
KR (1) KR890002111A (ko)
AT (1) ATE94164T1 (ko)
AU (1) AU602418B2 (ko)
CA (1) CA1310010C (ko)
DE (1) DE3883891T2 (ko)
DK (1) DK413188A (ko)
ES (1) ES2059550T3 (ko)
FI (1) FI883484A (ko)
FR (1) FR2618435B1 (ko)
HU (1) HUT47266A (ko)
IE (1) IE61824B1 (ko)
IL (1) IL87174A (ko)
NO (1) NO883263L (ko)
NZ (1) NZ225528A (ko)
PT (1) PT88089B (ko)
ZA (1) ZA885367B (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658823B1 (fr) * 1990-02-27 1992-04-30 Adir Nouveaux derives d'aminomethylpiperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent .
CA2097317C (en) * 1990-12-14 2002-02-12 Albert A. Carr Antiallergic piperdinyl benzimidazoles
FR2674853B1 (fr) * 1991-04-03 1995-01-20 Synthelabo Derives de piperidinylguanidine, leur preparation et leur application en therapeutique.
US5223704A (en) * 1992-03-31 1993-06-29 At&T Bell Laboratories Planar buried quantum well photodetector
FR2693194B1 (fr) * 1992-07-03 1994-09-23 Synthelabo Dérivés d'alcanecarboxamide, leur préparation et leur application thérapeutique.
FR2696176B1 (fr) * 1992-09-28 1994-11-10 Synthelabo Dérivés de pipéridine, leur préparation et leur application en thérapeutique.
EP3697410A4 (en) 2017-10-19 2021-08-11 Amgen Inc. BENZIMIDAZOLE DERIVATIVES AND THEIR USES

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3528991A (en) * 1964-02-19 1970-09-15 Sterling Drug Inc 1h- and 2h-benzotriazolyl-lower-alkyl-amidoximes,-amidines,and -guanidines
CA1140119A (en) * 1978-04-03 1983-01-25 Joseph Torremans N-heterocyclyl-4-piperidinamines
US4347856A (en) * 1980-05-20 1982-09-07 United States Tobacco Company Method and apparatus for removing cigar wrappers from the web of a bobbin
US4634704A (en) * 1983-10-06 1987-01-06 Janssen Pharmaceutica, N.V. Anti-allergic five membered heterocyclic ring containing N-(bicyclic heterocycyl)-4-piperidinamines
FR2587029B1 (fr) * 1985-09-11 1987-10-30 Synthelabo Derives de benzimidazole, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
EP0304353B1 (fr) 1993-09-08
NZ225528A (en) 1990-05-28
IL87174A0 (en) 1988-12-30
AU602418B2 (en) 1990-10-11
IL87174A (en) 1993-02-21
ES2059550T3 (es) 1994-11-16
IE61824B1 (en) 1994-11-30
DE3883891D1 (de) 1993-10-14
ZA885367B (en) 1989-06-28
NO883263D0 (no) 1988-07-22
HUT47266A (en) 1989-02-28
FI883484A0 (fi) 1988-07-22
JPS6434978A (en) 1989-02-06
DK413188A (da) 1989-01-24
CA1310010C (en) 1992-11-10
EP0304353A1 (fr) 1989-02-22
PT88089A (pt) 1989-06-30
ATE94164T1 (de) 1993-09-15
DK413188D0 (da) 1988-07-22
FR2618435A1 (fr) 1989-01-27
NO883263L (no) 1989-01-24
US4857536A (en) 1989-08-15
PT88089B (pt) 1995-03-01
AU1971688A (en) 1989-01-27
IE882257L (en) 1989-01-23
FR2618435B1 (fr) 1989-10-27
DE3883891T2 (de) 1994-04-14
FI883484A (fi) 1989-01-24
JP2690749B2 (ja) 1997-12-17

Similar Documents

Publication Publication Date Title
OA07151A (fr) Dérivés de la pyrrolidine .
DE3777852D1 (de) Dekahydrochinolinderivate, verfahren zu ihrer herstellung, zwischenprodukte zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende zubereitungen.
KR890002111A (ko) 벤즈이미다졸 유도체, 그의 제법 및 치료에의 이용
KR890017244A (ko) 6-페닐-3-(피페라지닐알킬)-2,4-(1h,3h)-피리미딘디온 유도체, 그의 제법 및 치료에의 이용
DE3869075D1 (de) 2-piperazinyl-2-oxo-aethylensubstituierte flavonoid-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammenstellungen.
KR890002103A (ko) 피페리딘 유도체, 그의제법 및 도르지발 38
KR930006003A (ko) 이미다졸릴메틸-피리딘류 화합물
KR850000455A (ko) 세팔로스포린 에스테르 유도체의 제조방법
KR890009901A (ko) 3-히드록시-2-(4-메톡시페닐)-5-(2-메틸아미노에틸)-2,3-디히드로-5h-1,5- 벤조티아제핀-4-온 유도체, 그의 제조 및 치료에의 이용
ATE70838T1 (de) Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung.
KR840006810A (ko) 세팔로스포린 에스테르의 제조방법
ATE22081T1 (de) Substituierte thienobenzodiazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
KR850000454A (ko) 세팔로스포린 유도체의 제조방법
ATE75468T1 (de) Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung.
KR850000456A (ko) 세팔로스포린 에스테르의 제조방법
MC1555A1 (fr) Dérivés de l'acridanone
KR930002303A (ko) N-아릴알킬파라히드록시페닐아세트아미드 유도체와 그의 제조방법
KR830009116A (ko) 세팔로스포린 유도체의 제조방법
KR850001211A (ko) 헥사히드로-인돌로-나프티리딘 유도체, 그의 제법 및 치료에의 응용
KR880007464A (ko) 신규의 치환피페리딘 또는 아제핀, 이것의 제조방법 및 치료적 사용방법
KR850007797A (ko) N-(3-페닐베멜티오-1-옥소프로필) 아미노 아세트산 유도체, 그의 제법 및 그를 포함하는 의약조성물

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application